Case–control study
Case–control study is a type of observational study in epidemiology that is often used to identify factors that may contribute to a medical condition by comparing subjects who have that condition/disease (the 'cases') with patients who do not have the condition/disease but are otherwise similar (the 'controls').
Overview[edit]
The case–control study design is often used in the study of rare diseases or as a preliminary study where little is known about the association between the risk factor and disease of interest. Compared to cohort studies, case–control studies are relatively quick and inexpensive, and they are particularly suitable for studying diseases with long latency periods.
Methodology[edit]
In a case–control study, an existing group of cases is defined at the start of the study. Then, a group of controls is selected to match the cases in terms of certain characteristics such as age, gender, or other variables. The exposure to the risk factor in each group is then retrospectively assessed.
Strengths and Weaknesses[edit]
Case–control studies have several strengths. They are efficient for rare diseases or diseases with a long latency period between exposure and disease manifestation. They are less costly and less time-consuming; they are advantageous when exposure data is expensive or hard to obtain. They are also advantageous when studying dynamic populations in which follow-up is difficult.
However, case–control studies also have inherent limitations. They are not suitable for studying rare exposures. Furthermore, the temporal sequence between exposure and outcome is not always clear. Recall bias, selection bias and observer bias are also of concern.
Examples[edit]
One of the most significant case–control studies was the Lung Health Study, which identified the link between tobacco smoking and lung cancer. Another notable case–control study was the British Doctors Study, which related tobacco smoking with various health effects including lung cancer and heart disease.
See also[edit]
This epidemiology-related article is a stub. You can help WikiMD by expanding it.
Sponsored Health Resource

W8MD Weight Loss, Sleep & MedSpa
Looking for physician-supervised weight loss, semaglutide, tirzepatide, or GLP-1 receptor agonist options? W8MD helps eligible patients in New York City, Brooklyn, New Jersey, Connecticut, Pennsylvania, Delaware, and greater Philadelphia with medical weight loss, sleep medicine, and long-term maintenance support.
GLP-1 specials: Affordable GLP-1 injections NYC and Philadelphia starting from $29.99/week and up for semaglutide with insurance accepted for qualifying visits, and $45/week and up for tirzepatide with insurance accepted for qualifying visits. Self-pay options start from $59.99/week and up for semaglutide and $69.99/week and up for tirzepatide.
- Medical weight loss NYC
- Affordable GLP-1 injections NYC
- Budget GLP-1 weight loss shots Philadelphia
- New Jersey medical weight loss
- NYC medical weight loss blog
- Philadelphia weight loss blog
- Sleep medicine and sleep apnea services
- W8MD MedSpa and wellness
Book a W8MD appointment · View GLP-1 specials
Paid promotional message. Eligibility, pricing, insurance coverage, medication availability, and results vary. Medical evaluation required.
Medical Disclaimer: WikiMD is for informational purposes only and is not a substitute for professional medical advice. Content may be inaccurate or outdated and should not be used for diagnosis or treatment. Always consult your healthcare provider for medical decisions. Verify information with trusted sources such as CDC.gov and NIH.gov. By using this site, you agree that WikiMD is not liable for any outcomes related to its content. See full disclaimer.
Credits:Most images are courtesy of Wikimedia commons, and templates, categories Wikipedia, licensed under CC BY SA or similar.
Translate page: - East Asian
中文,
日本,
한국어,
South Asian
हिन्दी,
தமிழ்,
తెలుగు,
Urdu,
ಕನ್ನಡ,
Southeast Asian
Indonesian,
Vietnamese,
Thai,
မြန်မာဘာသာ,
বাংলা
European
español,
Deutsch,
français,
Greek,
português do Brasil,
polski,
română,
русский,
Nederlands,
norsk,
svenska,
suomi,
Italian
Middle Eastern & African
عربى,
Turkish,
Persian,
Hebrew,
Afrikaans,
isiZulu,
Kiswahili,
Other
Bulgarian,
Hungarian,
Czech,
Swedish,
മലയാളം,
मराठी,
ਪੰਜਾਬੀ,
ગુજરાતી,
Portuguese,
Ukrainian